Viveve Medical, Inc. (VIVE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2021 | -13.81 Million USD | -1986.56% |
| 2020 | -662 Thousand USD | 92.69% |
| 2019 | -9.05 Million USD | -1001.19% |
| 2018 | 1 Million USD | -87.77% |
| 2017 | 8.21 Million USD | 432.6% |
| 2016 | 1.54 Million USD | 161.06% |
| 2015 | -2.52 Million USD | -257.45% |
| 2014 | 1.6 Million USD | -57.4% |
| 2013 | 3.76 Million USD | -51.94% |
| 2012 | 7.84 Million USD | 185.92% |
| 2011 | 2.74 Million USD | 307.1% |
| 2010 | -1.32 Million USD | 50.71% |
| 2009 | -2.68 Million USD | 46.56% |
| 2008 | -5.02 Million USD | 37.64% |
| 2007 | -8.06 Million USD | -33.58% |
| 2006 | -6.03 Million USD | -135.7% |
| 2005 | -2.56 Million USD | 73.55% |
| 2004 | -9.67 Million USD | -61.27% |
| 2003 | -6 Million USD | -32.21% |
| 2002 | -4.53 Million USD | -156.88% |
| 2001 | -1.76 Million USD | -162.95% |
| 2000 | -672 Thousand USD | 56.95% |
| 1999 | -1.56 Million USD | 56.64% |
| 1998 | -3.6 Million USD | -1000.0% |
| 1997 | 400 Thousand USD | 113.33% |
| 1996 | -3 Million USD | -328.57% |
| 1995 | -700 Thousand USD | 81.08% |
| 1994 | -3.7 Million USD | 17.78% |
| 1993 | -4.5 Million USD | -40.63% |
| 1992 | -3.2 Million USD | -357.14% |
| 1991 | -700 Thousand USD | 0.0% |
| 1990 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 Q1 | -8.52 Million USD | 38.28% |
| 2022 Q3 | -26 Thousand USD | 99.3% |
| 2022 Q2 | -3.73 Million USD | 56.2% |
| 2021 Q4 | -13.81 Million USD | 21.01% |
| 2021 FY | -13.81 Million USD | -1986.56% |
| 2021 Q1 | -22.26 Million USD | -4100.0% |
| 2021 Q2 | -20.37 Million USD | 8.46% |
| 2021 Q3 | -17.48 Million USD | 14.18% |
| 2020 Q1 | -4.65 Million USD | 48.61% |
| 2020 Q3 | -3.27 Million USD | -23.61% |
| 2020 Q2 | -2.65 Million USD | 43.04% |
| 2020 FY | -662 Thousand USD | 92.69% |
| 2020 Q4 | -530 Thousand USD | 83.83% |
| 2019 Q1 | 13.1 Million USD | 1204.08% |
| 2019 Q4 | -9.05 Million USD | -139.61% |
| 2019 FY | -9.05 Million USD | -1001.19% |
| 2019 Q2 | 22.01 Million USD | 67.96% |
| 2019 Q3 | 22.86 Million USD | 3.87% |
| 2018 Q2 | -489 Thousand USD | 94.59% |
| 2018 Q1 | -9.04 Million USD | -210.05% |
| 2018 FY | 1 Million USD | -87.77% |
| 2018 Q4 | 1 Million USD | -89.98% |
| 2018 Q3 | 10.02 Million USD | 2150.51% |
| 2017 Q1 | -21.72 Million USD | -1507.97% |
| 2017 FY | 8.21 Million USD | 432.6% |
| 2017 Q4 | 8.21 Million USD | 1616.24% |
| 2017 Q3 | -542 Thousand USD | 95.72% |
| 2017 Q2 | -12.66 Million USD | 41.69% |
| 2016 Q1 | -814 Thousand USD | 67.79% |
| 2016 Q2 | -10.37 Million USD | -1174.08% |
| 2016 Q3 | -4.41 Million USD | 57.42% |
| 2016 Q4 | 1.54 Million USD | 134.94% |
| 2016 FY | 1.54 Million USD | 161.06% |
| 2015 Q3 | -1.06 Million USD | 75.68% |
| 2015 FY | -2.52 Million USD | -257.45% |
| 2015 Q1 | 3.27 Million USD | 104.3% |
| 2015 Q4 | -2.52 Million USD | -138.17% |
| 2015 Q2 | -4.36 Million USD | -233.03% |
| 2014 Q4 | 1.6 Million USD | 417.71% |
| 2014 Q3 | -505.18 Thousand USD | -111.06% |
| 2014 Q2 | 4.56 Million USD | -4.4% |
| 2014 Q1 | 4.77 Million USD | 26.75% |
| 2014 FY | 1.6 Million USD | -57.4% |
| 2013 Q1 | 7.61 Million USD | -2.82% |
| 2013 Q3 | 4.38 Million USD | -7.15% |
| 2013 Q2 | 4.72 Million USD | -37.96% |
| 2013 FY | 3.76 Million USD | -51.94% |
| 2013 Q4 | 3.76 Million USD | -14.15% |
| 2012 Q1 | 6.89 Million USD | 151.6% |
| 2012 Q4 | 7.84 Million USD | -17.06% |
| 2012 Q3 | 9.45 Million USD | 19.31% |
| 2012 Q2 | 7.92 Million USD | 14.84% |
| 2012 FY | 7.84 Million USD | 185.92% |
| 2011 FY | 2.74 Million USD | 307.1% |
| 2011 Q4 | 2.74 Million USD | 34.94% |
| 2011 Q3 | 2.03 Million USD | 39.56% |
| 2011 Q2 | 1.45 Million USD | 654.4% |
| 2011 Q1 | 193 Thousand USD | 114.58% |
| 2010 Q4 | -1.32 Million USD | 0.08% |
| 2010 Q1 | -1.84 Million USD | 31.38% |
| 2010 FY | -1.32 Million USD | 50.71% |
| 2010 Q2 | -1.47 Million USD | 20.02% |
| 2010 Q3 | -1.32 Million USD | 10.11% |
| 2009 FY | -2.68 Million USD | 46.56% |
| 2009 Q1 | -4.31 Million USD | 14.07% |
| 2009 Q2 | -3.55 Million USD | 17.81% |
| 2009 Q3 | -3.25 Million USD | 8.39% |
| 2009 Q4 | -2.68 Million USD | 17.4% |
| 2008 Q1 | -6.84 Million USD | 15.14% |
| 2008 Q2 | -5.5 Million USD | 19.5% |
| 2008 Q4 | -5.02 Million USD | 9.23% |
| 2008 FY | -5.02 Million USD | 37.64% |
| 2008 Q3 | -5.53 Million USD | -0.56% |
| 2007 FY | -8.06 Million USD | -33.58% |
| 2007 Q2 | -8.64 Million USD | 14.21% |
| 2007 Q4 | -8.06 Million USD | 7.48% |
| 2007 Q3 | -8.71 Million USD | -0.78% |
| 2007 Q1 | -10.07 Million USD | -67.0% |
| 2006 Q2 | -4.89 Million USD | 2.72% |
| 2006 Q1 | -5.03 Million USD | -96.6% |
| 2006 FY | -6.03 Million USD | -135.7% |
| 2006 Q4 | -6.03 Million USD | -27.19% |
| 2006 Q3 | -4.74 Million USD | 3.1% |
| 2005 Q1 | -2.59 Million USD | 73.15% |
| 2005 Q4 | -2.56 Million USD | 9.12% |
| 2005 Q2 | -2.64 Million USD | -1.77% |
| 2005 FY | -2.56 Million USD | 73.55% |
| 2005 Q3 | -2.81 Million USD | -6.5% |
| 2004 Q3 | -9.8 Million USD | 2.92% |
| 2004 FY | -9.67 Million USD | -61.27% |
| 2004 Q1 | -10.62 Million USD | -76.97% |
| 2004 Q2 | -10.09 Million USD | 4.94% |
| 2004 Q4 | -9.67 Million USD | 1.24% |
| 2003 FY | -6 Million USD | -32.21% |
| 2003 Q4 | -6 Million USD | -6.93% |
| 2003 Q3 | -5.61 Million USD | 2.2% |
| 2003 Q2 | -5.73 Million USD | -31.52% |
| 2003 Q1 | -4.36 Million USD | 3.88% |
| 2002 Q2 | -3.13 Million USD | -19.5% |
| 2002 Q1 | -2.62 Million USD | -48.56% |
| 2002 FY | -4.53 Million USD | -156.88% |
| 2002 Q4 | -4.53 Million USD | -25.32% |
| 2002 Q3 | -3.62 Million USD | -15.46% |
| 2001 Q3 | -1.79 Million USD | 4.78% |
| 2001 Q2 | -1.88 Million USD | 28.88% |
| 2001 Q1 | -2.64 Million USD | -294.2% |
| 2001 FY | -1.76 Million USD | -162.95% |
| 2001 Q4 | -1.76 Million USD | 1.51% |
| 2000 Q4 | -672 Thousand USD | 69.37% |
| 2000 Q2 | -2.97 Million USD | 39.95% |
| 2000 Q1 | -4.94 Million USD | -217.04% |
| 2000 FY | -672 Thousand USD | 56.95% |
| 2000 Q3 | -2.19 Million USD | 26.18% |
| 1999 Q3 | -4 Million USD | -73.91% |
| 1999 FY | -1.56 Million USD | 56.64% |
| 1999 Q1 | -3.6 Million USD | 0.0% |
| 1999 Q2 | -2.3 Million USD | 36.11% |
| 1999 Q4 | -1.56 Million USD | 60.98% |
| 1998 Q2 | -6.9 Million USD | 30.3% |
| 1998 Q4 | -3.6 Million USD | 20.0% |
| 1998 Q3 | -4.5 Million USD | 34.78% |
| 1998 Q1 | -9.9 Million USD | -2575.0% |
| 1998 FY | -3.6 Million USD | -1000.0% |
| 1997 Q2 | -1.7 Million USD | 63.83% |
| 1997 Q3 | -400 Thousand USD | 76.47% |
| 1997 Q4 | 400 Thousand USD | 200.0% |
| 1997 FY | 400 Thousand USD | 113.33% |
| 1997 Q1 | -4.7 Million USD | -56.67% |
| 1996 Q2 | -4.3 Million USD | -2.38% |
| 1996 Q3 | -4.2 Million USD | 2.33% |
| 1996 Q4 | -3 Million USD | 28.57% |
| 1996 FY | -3 Million USD | -328.57% |
| 1996 Q1 | -4.2 Million USD | -500.0% |
| 1995 FY | -700 Thousand USD | 81.08% |
| 1995 Q4 | -700 Thousand USD | 0.0% |
| 1994 Q2 | -4 Million USD | 4.76% |
| 1994 Q3 | -11.5 Million USD | -187.5% |
| 1994 FY | -3.7 Million USD | 17.78% |
| 1994 Q4 | -3.7 Million USD | 67.83% |
| 1994 Q1 | -4.2 Million USD | 6.67% |
| 1993 Q2 | -5.2 Million USD | -100.0% |
| 1993 Q4 | -4.5 Million USD | 0.0% |
| 1993 Q3 | -4.5 Million USD | 13.46% |
| 1993 FY | -4.5 Million USD | -40.63% |
| 1993 Q1 | -2.6 Million USD | 18.75% |
| 1992 FY | -3.2 Million USD | -357.14% |
| 1992 Q3 | -4 Million USD | -900.0% |
| 1992 Q4 | -3.2 Million USD | 20.0% |
| 1992 Q2 | 500 Thousand USD | 200.0% |
| 1992 Q1 | -500 Thousand USD | 28.57% |
| 1991 FY | -700 Thousand USD | 0.0% |
| 1991 Q4 | -700 Thousand USD | 0.0% |
| 1990 FY | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 151.004% |
| BrainsWay Ltd. | -10.32 Million USD | -33.847% |
| Cerus Corporation | 84.35 Million USD | 116.375% |
| Envoy Medical, Inc. | -3.81 Million USD | -262.166% |
| electroCore, Inc. | -9.95 Million USD | -38.754% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | -169.522% |
| IceCure Medical Ltd | -9.93 Million USD | -39.048% |
| Inogen, Inc. | -103.56 Million USD | 86.663% |
| OrthoPediatrics Corp. | -9.26 Million USD | -49.056% |
| Lucid Diagnostics Inc. | -3.64 Million USD | -279.374% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | -5.467% |
| MaxCyte, Inc. | -27.76 Million USD | 50.247% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | -168.835% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -2299.061% |
| Orthofix Medical Inc. | 96.44 Million USD | 114.323% |
| PAVmed Inc | 29.08 Million USD | 147.49% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 18.454% |
| RxSight, Inc. | -6.68 Million USD | -106.781% |
| Sight Sciences, Inc. | -102.71 Million USD | 86.552% |
| SI-BONE, Inc. | 5.72 Million USD | 341.444% |
| TELA Bio, Inc. | -3.94 Million USD | -249.785% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 124.098% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 4024.148% |
| Acutus Medical, Inc. | 12.27 Million USD | 212.493% |
| Talis Biomedical Corporation | -57.06 Million USD | 75.794% |
| Spectral AI, Inc. | -3.5 Million USD | -294.544% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 71.239% |
| CVRx, Inc. | -59.95 Million USD | 76.961% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 796.169% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 1181.137% |
| Bioventus Inc. | 372.51 Million USD | 103.708% |
| Venus Concept Inc. | 74.3 Million USD | 118.591% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | -35.661% |
| LivaNova PLC | 62.53 Million USD | 122.089% |
| 908 Devices Inc. | -115.09 Million USD | 87.999% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 104.307% |
| Nemaura Medical Inc. | 9.92 Million USD | 239.174% |
| NeuroPace, Inc. | 54.33 Million USD | 125.421% |
| LENSAR, Inc. | -18.31 Million USD | 24.569% |
| Apyx Medical Corporation | -5.15 Million USD | -168.162% |
| Cutera, Inc. | 288.3 Million USD | 104.791% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 283.806% |
| BioSig Technologies, Inc. | 262 Thousand USD | 5372.137% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 68.485% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | -50.158% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.983% |
| Axonics, Inc. | -77.19 Million USD | 82.106% |
| Outset Medical, Inc. | 67.67 Million USD | 120.41% |
| IRIDEX Corporation | -4.28 Million USD | -222.132% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 92.241% |
| IRadimed Corporation | -47.71 Million USD | 71.054% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -356.477% |
| INVO Bioscience, Inc. | 8.45 Million USD | 263.445% |
| Telesis Bio, Inc. | 32.63 Million USD | 142.326% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -452.049% |
| Varex Imaging Corporation | 316.9 Million USD | 104.359% |
| Quipt Home Medical Corp. | 81.73 Million USD | 116.9% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -396.513% |
| Pulmonx Corporation | -42.36 Million USD | 67.391% |
| Dynatronics Corporation | 6.2 Million USD | 322.645% |
| Modular Medical, Inc. | -8.04 Million USD | -71.761% |
| ReShape Lifesciences Inc. | -4.29 Million USD | -221.457% |
| Semler Scientific, Inc. | -57.13 Million USD | 75.822% |
| InMode Ltd. | -135.39 Million USD | 89.798% |
| Bruker Corporation | 891.3 Million USD | 101.55% |
| Cytosorbents Corporation | 4.18 Million USD | 430.295% |
| DexCom, Inc. | 2.02 Billion USD | 100.681% |
| Align Technology, Inc. | -840.47 Million USD | 98.357% |
| ZimVie Inc. | 450.41 Million USD | 103.067% |
| Movano Inc. | -5.86 Million USD | -135.476% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 89.727% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -2299.061% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 796.169% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 103.871% |
| Profound Medical Corp. | -18.17 Million USD | 24.015% |
| Insulet Corporation | 798.1 Million USD | 101.731% |
| enVVeno Medical Corporation | -2.21 Million USD | -522.768% |
| Surmodics, Inc. | -12.01 Million USD | -14.974% |
| iCAD, Inc. | -21.2 Million USD | 34.872% |
| Nuwellis, Inc. | -2.81 Million USD | -389.996% |
| Biotricity, Inc. | 23.09 Million USD | 159.815% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 114.749% |
| Aethlon Medical, Inc. | -4.5 Million USD | -206.842% |
| InspireMD, Inc. | -8.04 Million USD | -71.697% |
| PAVmed Inc. | 29.08 Million USD | 147.49% |
| BIOLASE, Inc. | 11.34 Million USD | 221.765% |
| Beyond Air, Inc. | 6.22 Million USD | 321.753% |
| FONAR Corporation | -14.66 Million USD | 5.812% |
| AxoGen, Inc. | 32.26 Million USD | 142.81% |
| Vivani Medical, Inc. | 42 Thousand USD | 32988.095% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | -29.602% |
| Inari Medical, Inc. | -7.16 Million USD | -92.892% |
| UFP Technologies, Inc. | 40.77 Million USD | 133.877% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 550.137% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | -189.501% |
| Tenon Medical, Inc. | -1.25 Million USD | -1000.637% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | -81.607% |
| Co-Diagnostics, Inc. | -11.92 Million USD | -15.82% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.623% |
| Sintx Technologies, Inc. | 905 Thousand USD | 1626.298% |
| NanoVibronix, Inc. | -3.27 Million USD | -321.385% |
| Quanterix Corporation | -132.95 Million USD | 89.611% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -396.513% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 38.238% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 101.833% |
| TransMedics Group, Inc. | 121.13 Million USD | 111.403% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 47.238% |
| NeuroMetrix, Inc. | -1.49 Million USD | -826.382% |
| Hyperfine, Inc. | -75.61 Million USD | 81.733% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 109.076% |
| Biomerica, Inc. | -3.38 Million USD | -308.065% |
| Bone Biologics Corporation | -3.02 Million USD | -356.391% |
| AVITA Medical, Inc. | -26.23 Million USD | 47.342% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -651.355% |
| Silk Road Medical, Inc | 64.42 Million USD | 121.441% |